Sanofi's (SNY) Q1 net profit increased 9.6% to €1.08B as costs related to previous acquisitions fell.
However, revenue fell 2.6% to €7.84B and undershot forecasts of €7.99B, hurt by falling vaccine and animal health sales, and currency fluctuations.
Adjusted income dropped 3.2% to €1.55B and missed consensus of €1.57B.
Sales breakdown: Vaccines -9.9% to €628M; animal health -6.7% to €517M; pharmaceuticals -1.6% to €6.7B; diabetes +13% at constant currencies to €1.66B.
Shares are -2% in Paris. (PR)